Dolly Vance
Executive Vice President, Corporate Affairs and General Counsel
General Counsel
Analyst — Senior Advisor, Legal & Corporate Affairs
Earnings-call appearances
-
Rigel Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-03
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-02
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2022 Earnings Call2022-05-03
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-01-10
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-02
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q2 FY2021 Earnings Call2021-08-03
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-05
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q4 FY2020 Earnings Call2021-03-02
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q3 FY2020 Earnings Call2020-11-05
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-04
Rigel Pharmaceuticals Inc (RIGL)
-
Rigel Pharmaceuticals Inc Q1 FY2020 Earnings Call2020-05-05
Rigel Pharmaceuticals Inc (RIGL)